(Q33183242)

English

Pegylated liposomal tumor necrosis factor-alpha results in reduced toxicity and synergistic antitumor activity after systemic administration in combination with liposomal doxorubicin (Doxil) in soft tissue sarcoma-bearing rats

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Pegylated liposomal tumor necrosis factor-alpha results in reduced toxicity and synergistic antitumor activity after systemic administration in combination with liposomal doxorubicin (Doxil) in soft tissue sarcoma-bearing rats (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

1 reference

based on heuristic

inferred from title

Alexander Eggermont

5

object named as

Alexander M M Eggermont

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

author name string

Timo L M ten Hagen

1

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Ann L B Seynhaeve

2

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Sandra T van Tiel

3

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Dirk J Ruiter

4

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

language of work or name

0 references

publication date

1 January 2002

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

International Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

97

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

115-120

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Shock and tissue injury induced by recombinant human cachectin

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1578

21 January 2018

Tumor necrosis factor as an antineoplastic agent: pitfalls and promises

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1578

21 January 2018

Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1578

21 January 2018

Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1578

21 January 2018

Biodistribution and tumor localization of stealth liposomal tumor necrosis factor-alpha in soft tissue sarcoma bearing rats

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1578

21 January 2018

Polyethylene glycol-liposomal doxorubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the management of AIDS-related Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1578

21 January 2018

Tumour necrosis factor alpha increases melphalan concentration in tumour tissue after isolated limb perfusion

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1578

21 January 2018

TNF-alpha augments intratumoural concentrations of doxorubicin in TNF-alpha-based isolated limb perfusion in rat sarcoma models and enhances anti-tumour effects

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1578

21 January 2018

Low-dose tumor necrosis factor-alpha augments antitumor activity of stealth liposomal doxorubicin (DOXIL) in soft tissue sarcoma-bearing rats

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1578

21 January 2018

Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1578

21 January 2018

Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: a multicenter trial

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1578

21 January 2018

High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1578

21 January 2018

Antitumor effects of liposomal IL1? and TNF? against the pulmonary metastases of the B16F10 murine melanoma in syngeneic mice

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1578

21 January 2018

In vitro cytostatic effect of TNF (tumor necrosis factor) entrapped in immunoliposomes on cells normally insensitive to TNF.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1578

21 January 2018

Delivery of cytokines by liposomes. III. Liposome-encapsulated GM-CSF and TNF-alpha show improved pharmacokinetics and biological activity and reduced toxicity in mice

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1578

21 January 2018

Pharmacokinetics and tissue distribution of doxorubicin encapsulated in stable liposomes with long circulation times

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1578

21 January 2018

Identifiers

10.1002/IJC.1578

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33183242&oldid=1962014238"